{"id":13009,"date":"2019-04-09T15:12:49","date_gmt":"2019-04-09T19:12:49","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13009"},"modified":"2019-04-09T15:12:49","modified_gmt":"2019-04-09T19:12:49","slug":"optumrx-5-costly-drugs-coming-this-year","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13009","title":{"rendered":"OptumRx: 5 costly drugs coming this year"},"content":{"rendered":"<p>(By Alia Paavola for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>OptumRx <a href=\"https:\/\/www.optum.com\/resources\/library\/5-drugs-to-watch-2019.html\">released a list<\/a> of five new and potentially expensive treatments coming to the market in 2019 that\u00a0healthcare companies should pay attention to. They&#8217;re listed below:\u00a0 Continue reading <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/optumrx-5-costly-drugs-coming-this-year.html\">article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/05\/pills.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10356\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/05\/pills-300x225.jpg\" alt=\"\" width=\"300\" height=\"225\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/05\/pills-300x225.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/05\/pills.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Alia Paavola for Becker&#8217;s Hospital Review) OptumRx released a list of five new and potentially expensive treatments coming to<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-13009","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13009"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13009\/revisions"}],"predecessor-version":[{"id":13010,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13009\/revisions\/13010"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}